Andrew Kuykendall, MD, discusses the background, methods, and design of a phase 2 study which evaluated fedratinib.

Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Chronic myeloid (or myelogenous) leukaemia (CML), also known as chronic granulocytic leukaemia, is a cancer of the white blood cells. It is characterized by the increased and unregulated growth of ...

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Risk factors for chronic lymphocytic leukemia (CLL) include having a family history of CLL, being over the age of 50, exposure to certain chemicals, your biological sex, and your race. Chronic ...

[11] Given her age, concomitant CMML, the absence of crypt architectural distortion on pathology specimens and the predominantly monocytic infiltrate, IBD was thought to be a less likely diagnosis ...

Driving instructor Michael Kyriacos Efstratiou from Winchmore Hill was diagnosed with chronic myelomonocytic leukaemia (CMML) just before Christmas. His daughter, Ellianna Efstratiou ...

O’Neil, 35, was transferred to Maine Medical Center, where further tests showed that she has acute myeloid leukemia, a cancer of the blood and bone marrow. Often referred to as AML, it is the ...